Key Insights

Highlights

No notable highlights available yet

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

0.0%

0 terminated out of 3 trials

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 0 completed with results

Key Signals

Data Visualizations

Phase Distribution

3Total
Not Applicable (2)
P 2 (1)

Trial Status

Recruiting2
Not Yet Recruiting1

Clinical Trials (3)

Showing 3 of 3 trials
NCT07546825Not ApplicableNot Yet Recruiting

Laparotomy vs Laparoscopy in Endometrial Cancer Staging

NCT07210164Not ApplicableRecruiting

Pre-habilitation Within ERAS Protocol for Gynecologic Oncology Surgery: The Pre_ERAS Study

NCT05896020Phase 2RecruitingPrimary

A Study of SHR-A1811 in Subjects With Gynaecologic Oncology

Showing all 3 trials

Research Network

Activity Timeline